The last decade has witnessed great advances in our understanding of the genetic and
biological basis of childhood acute lymphoblastic leukemia (ALL), the development of …

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. One of the major
clinical challenges is adequate diagnosis and treatment of central nervous system (CNS) …

To identify the prognostic factors that are useful to improve central nervous system (CNS)
control in children with acute lymphoblastic leukemia (ALL), we analyzed the outcome of …

Acute leukemias (both myeloid and lymphoblastic) are a group of diseases for which each
year more successful therapies are implemented. However, in a subset of cases the overall …

Abstract Comparison of treatment strategies in de novo pediatric acute lymphoblastic
leukemia (ALL) requires standardized measures of efficacy. Key parameters that define …

To determine the prognostic significance of central nervous system (CNS) leukemic
involvement in newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL), outcomes on …

Background Boys with acute lymphoblastic leukemia (ALL) have historically experienced
inferior survival compared to girls. This study determined whether sex‐based disparities …

The central nervous system (CNS) is the most important site of extramedullary disease in
adults with acute lymphoblastic leukemia (ALL). Although CNS disease is identified only in a …

Acute Lymphoblastic Leukemia (ALL) is the most common cancer in childhood. Despite a
significantly improved prognosis over the last decade with a 5-years survival rate of~ 90 …

Background The cerebrospinal fluid (CSF) proteome could offer important insights into
central nervous system (CNS) malignancies. To advance proteomic research in pediatric …